BEVERLY, MA--(Marketwired - August 24, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical ... including the amount and timing of the sale of shares of common stock to Aspire Capital; the fact …
CTIX) Implant Sciences Corporation (OTCMKTS:IMSC) declined -3.20%, trading on 235,011 shares to end the trade at …
Stock-based compensation expense was $0.3 million for the ... Headquartered in Beverly, Massachusetts, Cellceutix is a publicly-traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing …
Two tid-bits kept Cellceutix Corp (OTCMKTS:CTIX) in the conversation as its Kevetrin drug candidate ... enrolment for a Phase 2 psoriasis drug trial ahead of schedule. The stock rose as much as 10% too. Solar3D (NASDAQ: SLTD) …
LONDON, Feb 21 (Reuters) - Sterling bounced off one-week lows on Wednesday after Bank of England policymakers struck a hawkish tone on inflation and interest rates in testimony to parliament. The pound had earlier been knocked …
The detection system offers one of the highest detection rates in its class HONG KONG, March 23, 2018 /PRNewswire/ …
More stocks rose than fell. On the New York Stock Exchange, rising shares topped falling ones 1,664 to 1,454 as 832 million shares traded. Nasdaq winners beat losers 2,008 to 1,658 as 1.1 billion shares changed hands. In other …
BEVERLY, MA--(Marketwired - September 08, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage ... including the amount and timing of the sale of shares of common stock to Aspire Capital; the fact that …